Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|3|4|289-301

ISSN： 1570-162X

Source： Current HIV Research, Vol.3, Iss.4, 2005-10, pp. : 289-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41

By  

Current HIV Research, Vol. 14, Iss. 3, 2016-05 ,pp. : 283-294

Bentham Science Publishers

Access to resources Recommend Favorite

Update on the development of HIV entry inhibitors

By Mastrolorenzo Antonio   Maresca Alfonso   Rusconi Stefano   Supuran Claudiu T  

Future HIV Therapy, Vol. 2, Iss. 5, 2008-09 ,pp. : 479-507

Future Medicine

Access to resources Recommend Favorite

Progress Towards the Development of a HIV-1 gp41-Directed Vaccine

By  

Current HIV Research, Vol. 2, Iss. 2, 2004-01 ,pp. : 193-204

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms and Modifications of Naturally Occurring Host Defense Peptides for Anti-HIV Microbicide Development

By  

Current HIV Research, Vol. 10, Iss. 1, 2012-01 ,pp. : 61-72

Bentham Science Publishers

Access to resources Recommend Favorite

An Algorithm for the Preclinical Development of Anti-HIV Topical Microbicides

By  

Current HIV Research, Vol. 10, Iss. 1, 2012-01 ,pp. : 97-104

Bentham Science Publishers

Access to resources Recommend Favorite